128 related articles for article (PubMed ID: 7541279)
1. Interaction of clozapine with the histamine H3 receptor in rat brain.
Rodrigues AA; Jansen FP; Leurs R; Timmerman H; Prell GD
Br J Pharmacol; 1995 Apr; 114(8):1523-4. PubMed ID: 7541279
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
3. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit.
Jansen FP; Mochizuki T; Maeyama K; Leurs R; Timmerman H
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):60-7. PubMed ID: 10935534
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain.
Jansen FP; Wu TS; Voss HP; Steinbusch HW; Vollinga RC; Rademaker B; Bast A; Timmerman H
Br J Pharmacol; 1994 Oct; 113(2):355-62. PubMed ID: 7834183
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus.
Alves-Rodrigues A; Timmerman H; Willems E; Lemstra S; Zuiderveld OP; Leurs R
Brain Res; 1998 Mar; 788(1-2):179-86. PubMed ID: 9555002
[TBL] [Abstract][Full Text] [Related]
6. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.
Alves-Rodrigues A; Leurs R; Wu TS; Prell GD; Foged C; Timmerman H
Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541
[TBL] [Abstract][Full Text] [Related]
7. Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors.
Kathmann M; Schlicker E; Göthert M
Psychopharmacology (Berl); 1994 Dec; 116(4):464-8. PubMed ID: 7701050
[TBL] [Abstract][Full Text] [Related]
8. The first radiolabeled histamine H3 receptor antagonist, [125I]iodophenpropit: saturable and reversible binding to rat cortex membranes.
Jansen FP; Rademaker B; Bast A; Timmerman H
Eur J Pharmacol; 1992 Jul; 217(2-3):203-5. PubMed ID: 1330590
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
Mezzomo K; Cumming P; Minuzzi L
Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
[TBL] [Abstract][Full Text] [Related]
10. The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics.
Schlicker E; Marr I
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):290-4. PubMed ID: 8692283
[TBL] [Abstract][Full Text] [Related]
11. A new potent and selective histamine H3 receptor agonist, 4-(1H-imidazol-4-ylmethyl)piperidine.
Vollinga RC; de Koning JP; Jansen FP; Leurs R; Menge WM; Timmerman H
J Med Chem; 1994 Feb; 37(3):332-3. PubMed ID: 8308858
[No Abstract] [Full Text] [Related]
12. Agonist and antagonist effects of histamine H3 receptor ligands on 5-HT3 receptor-mediated ion currents in NG108-15 cells.
Allen MC
Eur J Pharmacol; 1998 Nov; 361(2-3):261-8. PubMed ID: 9865516
[TBL] [Abstract][Full Text] [Related]
13. Identification and pharmacological characterization of the histamine H3 receptor in cultured rat astrocytes.
Mele T; Jurič DM
Eur J Pharmacol; 2013 Nov; 720(1-3):198-204. PubMed ID: 24432407
[TBL] [Abstract][Full Text] [Related]
14. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
Morisset S; Sahm UG; Traiffort E; Tardivel-Lacombe J; Arrang JM; Schwartz JC
J Pharmacol Exp Ther; 1999 Feb; 288(2):590-6. PubMed ID: 9918563
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.
Tedford CE; Yates SL; Pawlowski GP; Nalwalk JW; Hough LB; Khan MA; Phillips JG; Durant GJ; Frederickson RC
J Pharmacol Exp Ther; 1995 Nov; 275(2):598-604. PubMed ID: 7473144
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3-receptors in rat cerebral cortical membranes.
Clark EA; Hill SJ
Br J Pharmacol; 1995 Jan; 114(2):357-62. PubMed ID: 7881735
[TBL] [Abstract][Full Text] [Related]
17. Brain penetration of the histamine H3 receptor antagonists thioperamide and clobenpropit in rat and mouse, determined with ex vivo [125I]iodophenpropit binding.
Mochizuki T; Jansen FP; Leurs R; Windhorst AD; Yamatodani A; Maeyama K; Timmerman H
Brain Res; 1996 Dec; 743(1-2):178-83. PubMed ID: 9017245
[TBL] [Abstract][Full Text] [Related]
18. Novel histamine H3 receptor antagonists: synthesis and evaluation of formamidine and S-methylisothiourea derivatives.
Goto T; Sakashita H; Murakami K; Sugiura M; Kondo T; Fukaya C
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):305-11. PubMed ID: 9118445
[TBL] [Abstract][Full Text] [Related]
19. A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.
Ganellin CR; Fkyerat A; Bang-Andersen B; Athmani S; Tertiuk W; Garbarg M; Ligneau X; Schwartz JC
J Med Chem; 1996 Sep; 39(19):3806-13. PubMed ID: 8809168
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the specific binding of the histamine H3 receptor antagonist radioligand [3H]GR168320.
Brown JD; O'Shaughnessy CT; Kilpatrick GJ; Scopes DI; Beswick P; Clitherow JW; Barnes JC
Eur J Pharmacol; 1996 Sep; 311(2-3):305-10. PubMed ID: 8891613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
